NBM-200 non-invasive hemoglobin monitoring devices (r) orsense U.S., LLC:1613665 [25-007884]
Ended Purchase Order Awarded
- Contract number
- 75N90025P00693
- Awardee
-
Orsense U.s., LLC UEI JW9FCAVP51S4
- Awarding agency
-
NIH Clinical Center
National Institutes of Health, Department of Health and Human Services
- Obligated
- $17,971
Award facts
- Contract value 100% obligated
- $17,971.20 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 334510 Electromedical and Electrotherapeutic Apparatus Manufacturing
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Raleigh, NC 27617, USA
Award details come from SAM.gov/FPDS.
About this award
This federal contract award is for the purchase of NBM-200 non-invasive hemoglobin monitoring devices from Orsense U.S., LLC, a foreign-owned for-profit organization located in Raleigh, North Carolina. The contract has a ceiling value of $17,971.20 and is a firm fixed-price purchase order with an ultimate completion date of October 9, 2025. The funding agency is the National Institutes of Health (NIH) Clinical Center, a civilian government agency. The contract does not have a set-aside designation.
Quick answers
Who was awarded contract 75N90025P00693?
75N90025P00693 was awarded to Orsense U.s., LLC by NIH Clinical Center (National Institutes of Health) on September 9, 2025.
How much is contract 75N90025P00693 worth?
The government has obligated $17,971 on 75N90025P00693.
Was contract 75N90025P00693 competed?
The extent of competition for 75N90025P00693 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award